Fair Value Calculator Fair Value Calculator
EN DE

Pandox AB (PNDX-B) Fair Value & Analysis

Real Estate · SE · Market cap 33.3B SEK

PA Pandox AB PNDX-B · ST
Pricekr 168.20
Fair Valuekr 160.51
Upside-4.6%
Quality46/100
Watch Pandox AB for free, get notified when fair value or trend changes. Watch for free
Evidence: High Range kr 160.51 – kr 216.41 📤 Share as image

Fair value as of: Jul 18, 2026

From 24 valuation models · updated 3 days ago

Fair value updated Jul 18, 2026, revised from kr 167.10 to kr 160.51 (−3.9%) since Jul 5, 2026. Share price +0.7% over the past month.

Price vs Fair Value (12 months)

kr 198.39 kr 159.88 Fair Value kr 160.51 Jul 2025 Jul 2026

12‑month range kr 159.88 – kr 198.39 · fair‑value band kr 160.51 – kr 216.41 · the kr 168.20 price screens above the kr 160.51 fair value. As of Jul 18, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Pandox AB (PNDX-B) currently trades at kr 168.20, while our model-based Fair Value estimate is kr 160.51, implying the stock looks roughly 4.6% fairly valued today. We read business quality at 46/100 (below-average quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Pandox AB generated revenue of 7.6B SEK at a net margin of 48.0%. Revenue grew 11.0% year over year. It earns a return on equity of 11.0%. Net debt stands at 51.9B SEK. Fundamentals as of Jul 18, 2026

Our scenario range runs from kr 160.51 (bear case) to kr 216.41 (bull case); at kr 168.20, the current price sits within that range. The share trades about 16% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Real Estate peers we cover trades at -5% fair-value upside, at -5%, PNDX-B screens cheaper than that median.

Key figures & financial health

Revenue (TTM) 7.6B SEK
Revenue growth (YoY) +11.0%
Net margin 48.0%
Return on equity 11.0%
Free cash flow 2.0B SEK FY2025
P/E ratio 9.0
More key figures
Operating margin 53.0%
EPS (TTM) kr 18.83
Dividend yield 2.6%
EPS growth (YoY) +466%
Net debt 51.9B SEK FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 18, 2026. TTM = trailing twelve months.

About the company

Pandox AB (publ) owns, develops, and leases hotel properties to skilled hotel operators under long-term, turnover based leases with minimum guaranteed levels. Since their inception in 1995, they have grown into one of the largest hotel property owners in Europe. Their portfolio consists of 193 hotel properties with approximately 43,000 rooms across 11 countries in Northern Europe. The portfolio market value is approximately SEK 90bn. The headquarters is in Stockholm, and we are listed on Nasdaq Stockholm. Pandox AB (publ) was established on January 28, 1932 and incorporated in Sweden.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Pandox AB reported revenue of kr 7.5B in FY2025 versus kr 3.3B in FY2021, a compound +22.9%/yr. Reported net income was kr 3.1B in FY2025, compounding +50.6%/yr from FY2021.

Revenue +22.9%/yr
FY21 kr 3.3B
FY22 kr 5.7B
FY23 kr 6.9B
FY24 kr 7.1B
FY25 kr 7.5B
Net income +50.6%/yr
FY21 kr 610M
FY22 kr 4.2B
FY23 −kr 585M
FY24 kr 1.7B
FY25 kr 3.1B

Is PNDX-B fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Pandox AB Fair Value". https://www.fairvalue-calculator.com/stock/PNDX-B

Similar stocks

10 more Real Estate Services stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).

Stock Price Fair Value vs Fair Value
Vingroup Joint Stock Company VIC 229,000 VND 25,731 VND -89%
KE Holdings 2423 HK$38.90 HK$17.91 -54%
Swire Properties Limited 1972 HK$20.40 HK$18.75 -8%
China Resources Mixc Lifestyle Services Limited 1209 HK$36.68 HK$34.70 -5%
Plaza S.A MALLPLAZA 3,732 CLP 6,475 CLP +74%
SAGAA SAGAA kr 147.00 kr 108.52 -26%
PT Solusi Tunas Pratama Tbk SUPR 43,850 IDR 17,713 IDR -60%
Cencosud Shopping S.A CENCOMALLS 2,420 CLP 3,226 CLP +33%
WHA Corporation WHA 4.98 THB 5.15 THB +3%
PT Sarana Menara Nusantara Tbk. owns and TOWR 322.00 IDR 780.11 IDR +142%

Explore undervalued stocks

More undervalued Real Estate stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Pandox AB (PNDX-B) undervalued?
As of Jul 18, 2026, our model estimates a fair value of kr 160.51 versus a price of kr 168.20, about −5% (fairly valued). Model-based estimate, not financial advice.
What is the fair value of PNDX-B?
Our model-based fair value for Pandox AB is kr 160.51 (as of Jul 18, 2026), built from audited fundamentals. The current price is kr 168.20.
What is the quality score of PNDX-B?
Pandox AB has a Quality Score of 46/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Pandox AB (PNDX-B)?
Pandox AB reported trailing-twelve-month revenue of about 7.6B SEK (latest available figure, as of Jul 18, 2026).
What is the net profit margin of PNDX-B?
The net profit margin of Pandox AB is about 48.0%, meaning it keeps roughly 48.0% of revenue as net income. Based on the latest reported figures.
Does Pandox AB pay a dividend?
Pandox AB currently shows a dividend yield of about 2.62% relative to its recent price (as of Jul 18, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full Pandox AB analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.